Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06075264 · ClinicalTrials.gov registry record · Phase 2

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

A Phase 2 study of HPV Infection and Vulvar Diseases, sponsored by Frantz Viral Therapeutics.

Recruiting
Registry status
Phase 2
Development phase
27
Enrollment target
5
Study locations

NCT06075264 is a Phase 2 study of HPV Infection and Vulvar Diseases that is actively recruiting participants, run by Frantz Viral Therapeutics. The registered enrollment target is 27 participants, below the 234-participant average among 13 other HPV Infection trials with a reported enrollment target (88% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06075264, a Phase 2 study of HPV Infection and Vulvar Diseases, is actively recruiting participants, sponsored by Frantz Viral Therapeutics.

RECRUITING
Registry status
Phase 2
Development phase
27 participants
Enrollment target
5
Study locations

Study Summary

This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).

Conditions Studied

HPV Infection Vulvar Diseases Pre-Cancerous Dysplasia HPV Disease Vulvar HSIL VIN, Usual Type VIN 2 of Usual Type VIN 3 of Usual Type Vin II Vin III

Interventions

  • DRUG Artesunate ointment
  • DRUG Placebo ointment

Study Locations (5)

Ohio

  • Cleveland Clinic Fairview Hospital - Cleveland
  • Cleveland Clinic Foundation - Cleveland
  • Hillcrest Hospital - Mayfield Heights

Florida

  • Florida Gynecologic Oncology - Fort Myers

Indiana

  • Ascension St. Vincent - Indianapolis

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2023-12-06
Est. Completion 2027-12
Phase Phase 2

Sponsor

Frantz Viral Therapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06075264

The ClinicalTrials.gov registry entry for NCT06075264 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 234-participant average among 13 other HPV Infection trials with a reported enrollment target (88% lower). The listed sponsor is Frantz Viral Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with HPV Infection appearing as the primary indexed condition, and to 2 interventions - of which Artesunate ointment is the first listed.

NCT06075264 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Ohio, Florida, Indiana.

Frequently Asked Questions

What is clinical trial NCT06075264 about?

NCT06075264 is a clinical study titled "Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)". This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).

What is the current status of trial NCT06075264?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2023-12-06. Estimated completion is 2027-12.

What conditions does trial NCT06075264 study?

This clinical trial studies the following conditions: HPV Infection, Vulvar Diseases, Pre-Cancerous Dysplasia, HPV Disease, Vulvar HSIL.

What interventions are being tested in trial NCT06075264?

The interventions under investigation include: Artesunate ointment (DRUG), Placebo ointment (DRUG).

Who is sponsoring clinical trial NCT06075264?

This trial is sponsored by Frantz Viral Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06075264 being conducted?

This trial has 5 study locations across Florida, Indiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HPV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HPV Infection

All registered trials for this condition

Vulvar Diseases

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.